Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Lung Cancer

  Free Subscription


2 AJR Am J Roentgenol
1 Am J Surg
1 Ann Oncol
2 Ann Thorac Surg
2 BMC Cancer
2 Cancer Lett
6 Cancer Sci
1 Chest
3 Clin Lung Cancer
1 Clin Nucl Med
2 Eur J Cancer
1 Eur J Cardiothorac Surg
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
2 J Cancer Res Clin Oncol
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Surg Oncol
1 J Thorac Cardiovasc Surg
1 J Thorac Oncol
3 Lung Cancer
1 Mol Cancer Ther
1 Mol Carcinog
3 PLoS One
1 Thorax

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

    Editorial Comment: Diagnosing Mediastinal Lymph Node Involvement in Non Small Cell Lung Cancer Noninvasively With Advanced Imaging Markers-Are We There Yet?
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26661.

  2. STEFANIDIS K, Konstantelloy E, Yusuf G, Moser J, et al
    The Evolving Landscape of Lung Cancer Surgical Resection: An Update for Radiologists With Focus on Key Chest CT Findings.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26408.
    PubMed         Abstract available

    Am J Surg

  3. JOHNSON BA, Waddimba AC, Ogola GO, Fleshman JW Jr, et al
    A systematic review and meta-analysis of surgery delays and survival in breast, lung and colon cancers: Implication for surgical triage during the COVID-19 pandemic.
    Am J Surg. 2021;222:311-318.
    PubMed         Abstract available

    Ann Oncol

  4. CORTELLINI A, Ricciuti B, Facchinetti F, Alessi JVM, et al
    Antibiotic-exposed patients with non-small cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy.
    Ann Oncol. 2021 Aug 13. pii: S0923-7534(21)03973.
    PubMed         Abstract available

    Ann Thorac Surg

  5. LIN KH, Huang YJ, Lee SC, Huang HK, et al
    Benefit of three-dimensional image simulation in surgical resection of early stage lung cancer.
    Ann Thorac Surg. 2021 Aug 10. pii: S0003-4975(21)01392.
    PubMed         Abstract available

  6. HEIDEN BT, Mitchell JD, Rome E, Puri V, et al
    Cost-effectiveness Analysis of Robotic-assisted Lobectomy for Non-small Cell Lung Cancer.
    Ann Thorac Surg. 2021 Aug 10. pii: S0003-4975(21)01389.
    PubMed         Abstract available

    BMC Cancer

  7. ZHANG X, Cao Y, Chen L
    Construction of a prognostic signature of autophagy-related lncRNAs in non-small-cell lung cancer.
    BMC Cancer. 2021;21:921.
    PubMed         Abstract available

  8. FEIL C, Staib F, Berger MR, Stein T, et al
    Sniffer dogs can identify lung cancer patients from breath and urine samples.
    BMC Cancer. 2021;21:917.
    PubMed         Abstract available

    Cancer Lett

  9. PARK MS, Yang AY, Lee JE, Kim SK, et al
    GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent manner.
    Cancer Lett. 2021 Aug 17. pii: S0304-3835(21)00404.
    PubMed         Abstract available

  10. TAROMI S, Firat E, Simonis A, Braun LM, et al
    Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer.
    Cancer Lett. 2021 Aug 15. pii: S0304-3835(21)00401.
    PubMed         Abstract available

    Cancer Sci

  11. MORI K, Higurashi M, Ishikawa F, Shibanuma M, et al
    Rac1-mediated sustained beta4 integrin level develops reattachment ability of breast cancer cells after anchorage loss.
    Cancer Sci. 2021;112:3205-3217.
    PubMed         Abstract available

  12. ZHANG Y, Li J, Wang B, Chen T, et al
    LDH-A negatively regulates dMMR in colorectal cancer.
    Cancer Sci. 2021;112:3050-3063.
    PubMed         Abstract available

  13. WANG Y, Chen D, Liu Y, Zhang Y, et al
    AQP3-mediated H2 O2 uptake inhibits LUAD autophagy by inactivating PTEN.
    Cancer Sci. 2021;112:3278-3292.
    PubMed         Abstract available

  14. LIU L, Yan H, Ruan M, Yang H, et al
    An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth.
    Cancer Sci. 2021;112:3083-3098.
    PubMed         Abstract available

  15. ZHANG C, Wang J, Sun Z, Cao Y, et al
    Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.
    Cancer Sci. 2021;112:3005-3017.
    PubMed         Abstract available

  16. TOMITA T, Kato M, Hiratsuka S
    Regulation of vascular permeability in cancer metastasis.
    Cancer Sci. 2021;112:2966-2974.
    PubMed         Abstract available


  17. KUNITOMO Y, Bade B, Gunderson CG, Akgun KM, et al
    Racial Differences in Adherence to Lung Cancer Screening Follow-Up: A Systematic Review and Meta-Analysis.
    Chest. 2021 Aug 11. pii: S0012-3692(21)03664.
    PubMed         Abstract available

    Clin Lung Cancer

  18. SINGH S, Pavesi F, Steiling K, Asokan S, et al
    Risk Factors for Lung Cancer in an Underrepresented Safety-Net Screening Cohort.
    Clin Lung Cancer. 2021 Jul 19. pii: S1525-7304(21)00190.
    PubMed         Abstract available

  19. YU HA, Goldberg SB, Le X, Piotrowska Z, et al
    Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD).
    Clin Lung Cancer. 2021 Jun 25. pii: S1525-7304(21)00157.
    PubMed         Abstract available

  20. UMEMURA S, Chen V, Chahine JJ, Kallakury B, et al
    Arginase Pathway Markers of Immune-Microenvironment in Thymic Epithelial Tumors and Small Cell Lung Cancer.
    Clin Lung Cancer. 2021 Jul 20. pii: S1525-7304(21)00187.
    PubMed         Abstract available

    Clin Nucl Med

  21. TANG W, Wu J, Yang S, Wang Q, et al
    Organizing Pneumonia With Intense 68Ga-FAPI Uptake Mimicking Lung Cancer on 68Ga-FAPI PET/CT.
    Clin Nucl Med. 2021 Aug 5. pii: 00003072-900000000-95878.
    PubMed         Abstract available

    Eur J Cancer

  22. LIN YT, Chiang CL, Hung JY, Lee MH, et al
    Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non-small-cell lung cancer: a multicenter study using targeted next-generation sequencing.
    Eur J Cancer. 2021;156:1-11.
    PubMed         Abstract available

  23. CORTELLINI A, Bersanelli M, Pinato DJ, Buti S, et al
    Response to letter entitled: Re: Predictive ability of a drug-based score in advanced non-small cell lung cancer patients receiving first-line immunotherapy.
    Eur J Cancer. 2021 Aug 12. pii: S0959-8049(21)00459.

    Eur J Cardiothorac Surg

  24. HOEIJMAKERS F, Hartemink KJ, Verhagen AF, Steup WH, et al
    Variation in incidence, prevention and treatment of persistent air leak after lung cancer surgery.
    Eur J Cardiothorac Surg. 2021 Aug 19. pii: 6354830. doi: 10.1093.
    PubMed         Abstract available

    Int J Cancer

  25. RISSANEN E, Heikkinen S, Seppa K, Ryynanen H, et al
    Incidence trends and risk factors of lung cancer in never smokers - Pooled analyses of seven cohorts.
    Int J Cancer. 2021 Aug 16. doi: 10.1002/ijc.33765.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  26. KRUSER TJ, Robinson C, Owen D, Salama JK, et al
    Strike or Spare? A Review of Lung-Sparing Therapies for Malignant Pleural Mesothelioma.
    Int J Radiat Oncol Biol Phys. 2021;110:257-260.

    J Cancer Res Clin Oncol

  27. KASHIWABARA K, Fujii S, Tsumura S, Sakamoto K, et al
    Efficacy and safety of transbronchial microwave ablation therapy under moderate sedation in malignant central airway obstruction patients with respiratory failure: a single-institution retrospective study.
    J Cancer Res Clin Oncol. 2021;147:2751-2757.
    PubMed         Abstract available

  28. GROGG JB, Fronzaroli JN, Oliveira P, Bode PK, et al
    Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: analysis of published case-series data.
    J Cancer Res Clin Oncol. 2021;147:2671-2679.
    PubMed         Abstract available

    J Clin Oncol

  29. GYAWALI B, West HJ
    Lessons From ADAURA on Adjuvant Cancer Drug Trials: Evidence, Ethics, and Economics.
    J Clin Oncol. 2021;39:175-177.

    J Natl Cancer Inst

  30. ZHAO W, Zhu B, Hutchinson A, Pesatori AC, et al
    Clinical Implications of Inter- and Intra-Tumor Heterogeneity of Immune Cell Markers in Lung Cancer.
    J Natl Cancer Inst. 2021 Aug 17. pii: 6353611. doi: 10.1093.
    PubMed         Abstract available

    J Surg Oncol

  31. CORSINI EM, Mitchell KG, Zhou N, Bernatchez C, et al
    Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.
    J Surg Oncol. 2021;124:699-703.
    PubMed         Abstract available

    J Thorac Cardiovasc Surg

  32. FARMER DM, Ripley RT
    Commentary: EGFR mutations lung adenocarcinoma-Is the driver removed with the lobe?
    J Thorac Cardiovasc Surg. 2021;162:675-676.

    J Thorac Oncol

  33. QUAIFE SL, Dickson JL, Brain KE, Kurtidu C, et al
    Psychological targets for lung cancer screening uptake: a prospective longitudinal cohort study.
    J Thorac Oncol. 2021 Aug 14. pii: S1556-0864(21)02369.
    PubMed         Abstract available

    Lung Cancer

  34. BUMA AIG, Muller M, de Vries R, Sterk PJ, et al
    eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer.
    Lung Cancer. 2021;160:36-43.
    PubMed         Abstract available

  35. STEENDAM CMJ, Peric R, van Walree NC, Youssef M, et al
    Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma.
    Lung Cancer. 2021;160:44-49.
    PubMed         Abstract available

  36. VERMA V
    Stereotactic radiotherapy for early-stage (T1-2N0) small cell lung cancer: Where are we now and where are we going?
    Lung Cancer. 2021 Aug 3. pii: S0169-5002(21)00485.

    Mol Cancer Ther

  37. BASCHNAGEL AM, Elnaggar JH, VanBeek HJ, Kromke AC, et al
    ATR inhibitor M6620 (VX-970) enhances the effect of radiation in non-small cell lung cancer brain metastasis patient derived xenografts.
    Mol Cancer Ther. 2021 Aug 19. pii: 1535-7163.MCT-21-0305.
    PubMed         Abstract available

    Mol Carcinog

  38. HU W, Ma Y, Zhao C, Yin S, et al
    Methylseleninic acid overcomes programmed death-ligand 1-mediated resistance of prostate cancer and lung cancer.
    Mol Carcinog. 2021 Aug 19. doi: 10.1002/mc.23340.
    PubMed         Abstract available

    PLoS One

  39. HUANG L, Bommireddy R, Munoz LE, Guin RN, et al
    Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor.
    PLoS One. 2021;16:e0254125.
    PubMed         Abstract available

  40. PHAM DAT, Le SD, Doan TM, Luu PT, et al
    Standardization of DNA amount for bisulfite conversion for analyzing the methylation status of LINE-1 in lung cancer.
    PLoS One. 2021;16:e0256254.
    PubMed         Abstract available

  41. SUN Z, Nyberg R, Wu Y, Bernard B, et al
    Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers.
    PLoS One. 2021;16:e0247238.
    PubMed         Abstract available


  42. HALL H, Tocock A, Burdett S, Fisher D, et al
    Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review.
    Thorax. 2021 Aug 17. pii: thoraxjnl-2021-216865.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.